Biobanking Research Report 2025: A $194 Billion Market by 2035 - Accelerated Growth Driven by Multi-Omics and AI Integration
Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The "Biobanking Market Report 2025-2035" report has been added to ResearchAndMarkets.com's offering.
This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Accelerated Market Growth Driven by Multi-Omics and AI Integration
The global biobanking market-valued at US$83.1 billion in 2025 and projected to reach US$194.0 billion by 2035 is accelerating as the sector transitions from conventional sample storage to large-scale, data-rich, multi-omics and AI-enabled research infrastructure. Historically centred on limited academic repositories, biobanks have evolved into globally interconnected platforms managing millions of high-quality samples linked to clinical, genomic, and proteomic datasets.
This transformation reflects a broader industry shift toward the active utilisation of biospecimens in sequencing, biomarker discovery, drug development, and translational medicine. Large national and institutional initiatives-such as advanced proteomic mapping involving hundreds of thousands of samples demonstrate the sector's expanding role.
Notably, on 13 January 2025, Illumina announced a pilot proteomics programme analysing 50,000 UK Biobank samples alongside deCODE Genetics, Standard BioTools, Tecan, GSK, Johnson & Johnson, and Novartis, leveraging its next-generation Illumina Protein Prep,N platform. Such collaborations highlight how modern biobanks are becoming critical engines for precision medicine, disease-risk analysis, and long-term population health research, driving robust market expansion.
What would be the Impact of US Trade Tariffs on the Global Biobanking Market?
U.S. trade tariffs are exerting upward pressure on cost structures across the biobanking value chain, particularly for imported ultra-low-temperature freezers, cryogenic systems, automation modules, consumables, and LIMS-related hardware. These cost increases are prompting biobanks to reassess procurement and shift toward regional or tariff-exempt suppliers to maintain budget stability.
The tariffs are also slowing infrastructure upgrades, delaying expansion timelines, and constraining capital allocation for advanced automation and digitalisation projects. In response, global suppliers are restructuring manufacturing footprints, while service providers adjust pricing for storage and processing to offset rising costs. Overall, the tariff environment is accelerating trends toward localisation, multi-vendor sourcing, and financially disciplined operational planning across the biobanking sector.
Key Questions Answered
You need to discover how this will impact the Biobanking market today, and over the next 10 years:
Market Dynamics
Market Driving Factors
Market Restraining Factors
Market Opportunities
U.S. Tariffs: What's the Impact on Global Biobanking Market?
Porter's Five Forces Analysis
PEST Analysis
Companies Featured
For more information about this report visit https://www.researchandmarkets.com/r/gewsz7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.